| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.47 | 7e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |